Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endocrine System Diseases × Bevacizumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 112 Breast Neoplasms 87 Carcinoma, Non-Small-Cell Lung 83 Glioblastoma 70 Ovarian Neoplasms 61 Brain Neoplasms 45 Lung Neoplasms 41 Glioma 41 Fallopian Tube Neoplasms 41 Neoplasms 38 Colonic Neoplasms 34 Gliosarcoma 33 Carcinoma, Renal Cell 32 Rectal Neoplasms 31 Neoplasm Metastasis 29 Pancreatic Neoplasms 19 Carcinoma, Hepatocellular 19 Melanoma 18 Adenocarcinoma of Lung 18 Astrocytoma 15 Kidney Neoplasms 13 Stomach Neoplasms 12 Prostatic Neoplasms 12 Uterine Cervical Neoplasms 11 Oligodendroglioma 11 Liver Neoplasms 11 Esophageal Neoplasms 11 Sarcoma 10 Adenocarcinoma, Bronchiolo-Alveolar 10 Central Nervous System Neoplasms 9

Interventions

Gemcitabine 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 Cisplatin 2 pralsetinib 1 parathyroid hormone-related peptide (1-36) 1 napabucasin 1 Thalidomide 1 Melphalan 1 Irinotecan 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Bortezomib 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡